Top Markets
#1 Islamic Coin Islamic Coin +151.49%
#2 DOVU DOVU +48.08%
#3 Akedo Akedo +40.50%
#4 Velvet Velvet +35.26%
#5 Black Phoenix Black Phoenix +34.23%
#6 Cross Cross +19.18%
#7 DoubleZero DoubleZero +18.36%
#8 Tutorial Tutorial +15.48%
#9 Cap Cap +14.84%
#10 Not in Employment, Education, or Training Not in Employment, Education, or Training +10.23%
Coin of the day
Islamic Coin Islamic Coin
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
PHAXIAM Therapeutics S.A. PHAXIAM Therapeutics S.A.

PHAXIAM Therapeutics S.A.

PHXM
Kedudukan dalam Saham #39465
PHAXIAM Therapeutics S.A. is a biopharmaceutical firm dedicated to creating... PHAXIAM Therapeutics S.A. is a biopharmaceutical firm dedicated to creating therapies for drug-resistant bacterial infections, operating in both France and the U.S. The company's pipeline includes eryaspase, currently undergoing Phase 3 clinical trials for advanced pancreatic cancer and Phase 2 studies for treating triple-negative breast cancer and acute lymphoblastic leukemia after initial treatments. Additionally, PHAXIAM is advancing a range of phage therapies designed to combat hazardous, drug-resistant bacteria. These pathogens, such as Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa, are responsible for over two-thirds of all resistant infections acquired in hospital settings. Established in 2004, the company was previously known as ERYTECH Pharma S.A. before adopting the name PHAXIAM Therapeutics S.A. in June 2023. Its corporate headquarters are located in Lyon, France.
Harga Saham
$0.11725176
Disegerakkan terakhir: 2025-07-14
Modal Pasaran
$481.50K
Perubahan (1 hari)
-0.20%
Perubahan (1 tahun)
0.00%
Negara
FR
Perdagangan PHAXIAM Therapeutics S.A. (PHXM)

Kategori

Healthcare
Margin Operasi untuk PHAXIAM Therapeutics S.A. (PHXM)
Margin Operasi pada August 2026 TTM: -1,784.31%
Menurut laporan kewangan dan harga saham terkini PHAXIAM Therapeutics S.A., margin operasi semasa (TTM) ialah -1,784.31%. Pada akhir 2022, margin operasi syarikat ialah -482.67%.
Sejarah Margin Operasi untuk PHAXIAM Therapeutics S.A. dari 2016 hingga 2026
Margin Operasi pada akhir setiap tahun
Tahun Margin Operasi Ubah
2026 (TTM) -1,784.31% 0.00%
2023 -1,784.31% 269.67%
2022 -482.67% -66.76%
2021 -1,452.03% -25.59%
2020 -1,951.32% 48.63%
2019 -1,312.83% 0.00%
2018 0.00% 0.00%
2017 0.00% 0.00%
2016 0.00% 0.00%
Margin Operasi untuk syarikat serupa atau pesaing
Syarikat Margin Operasi Perbezaan Margin Operasi Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
38.97% -100.02%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
28.81% -100.02%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00% -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
0.00% -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
31.23% -100.02%
BE
Apakah Margin Operasi sesebuah syarikat?
Margin Operasi ialah penunjuk utama untuk menilai keuntungan sesebuah syarikat. Margin Operasi yang lebih tinggi lazimnya lebih baik kerana menunjukkan bahawa syarikat mampu menjual produk atau perkhidmatannya dengan harga yang jauh lebih tinggi daripada kos pengeluarannya. Ia dikira dengan membahagikan keuntungan syarikat dengan hasilnya.